Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials-Reference-Cited by-同舟云学术

Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials

Published:2018-01 Issue:1 Volume:126 Page:155-162
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Haviland Joanne S,Mannino Mariella,Griffin Clare,Porta Nuria,Sydenham Mark,Bliss Judith M.,Yarnold John R.

Funder

Cancer Research UK

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference18 articles.

1. Long-term results of hypofractionated radiation therapy for breast cancer;Whelan;N Engl J Med,2010

2. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial;Yarnold;Radiother Oncol,2005

3. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial;START Trialists’ Group;Lancet Oncol,2008

4. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial;START Trialists’ Group;Lancet,2008

5. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials;Haviland;Lancet Oncol,2013

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis;BMJ;2024-09-11

2. Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both the Worlds;Clinical Breast Cancer;2024-07

3. Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands;Clinical and Translational Radiation Oncology;2024-07

4. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial;Radiation Oncology;2024-05-27

5. Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study;International Journal of Radiation Oncology*Biology*Physics;2024-04